Cannabix Technologies Develops Beta Marijuana Breathalyzer

Cannabix Technologies (CSE:BLO,OTC Pink:BLOZF) has developed a stand-alone desktop sized beta FAIMS (high-field asymmetric waveform ion mobility spectrometry) marijuana breathalyzer.
As quoted in the press release:

Preliminary lab tests of the FAIMS device coupled with conventional quadrupole mass spectrometry have shown similar levels of detection for THC standards.
The FAIMS cell employed in this device is 4X smaller than the prior benchtop version and has a 10X reduction in power supply requirements, which allows a drastically smaller footprint. The current power supply is readily configurable for ongoing testing and is designed to integrate with the non-radioactive ionization source and soon to be implemented customized detector.  The Company expects to complete a “Beta 2.0” device that will be prepared for external testing. With ongoing technical advances, the company is rapidly reducing the size of each internal component and is improving the engineering of the electronics.

Click here for the full press release.